Journal article

Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer

KK Yap, KSK Yap, AJ Byrne, SU Berlangieri, A Poon, P Mitchell, SR Knight, PC Clarke, A Harris, A Tauro, CC Rowe, AM Scott

European Journal of Nuclear Medicine and Molecular Imaging | SPRINGER | Published : 2005

Abstract

PURPOSE: (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging is an important staging procedure in patients with non-small cell lung cancer (NSCLC). We aimed to demonstrate, through a decision tree model and the incorporation of real costs of each component, that routine FDG-PET imaging as a prelude to curative surgery will reduce requirements for routine mediastinoscopy and overall hospital costs. METHODS: A decision tree model comparing routine whole-body FDG-PET imaging to routine staging mediastinoscopy was used, with baseline variables of sensitivity, specificity and prevalence of non-operable and metastatic disease obtained from institutional data and a literature re..

View full abstract